US Broker Ratings

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 137.94% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a notable player in the biotechnology industry, is capturing the attention of investors with its promising potential upside of 137.94%. As a biopharmaceutical leader headquartered..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Unpacking a 73.66% Potential Upside

For investors with an interest in innovative healthcare solutions, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) offers a compelling narrative. Specializing in surgical robotics, PROCEPT is making significant inroads in the medical..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 52.54% Potential Upside in the Medical Devices Sector

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, specifically within the medical devices industry, stands out with a market capitalization of $2.7 billion. Known for its cutting-edge..

Metsera, Inc. (MTSR) Stock Analysis: Navigating the -19.15% Potential Downside in the Biotechnology Sector

Metsera, Inc. (MTSR) stands out in the biotechnology sector with its innovative approach to addressing obesity and related diseases through the development of hormone analog peptides. As a clinical-stage company,..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Uncovering a 218% Upside Potential in Biotech

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, is gaining significant attention in the investor community due to its promising pipeline and remarkable upside potential. With a market cap..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Unpacking a 36.64% Potential Upside in Rare Disease Biotech

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is gaining attention from investors with its significant potential upside of 36.64%, according to the latest analyst ratings. This Boston-based biotechnology company is focused on..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Is a 15.86% Potential Upside Enough to Attract Investors?

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) has made a name for itself in the biotechnology sector, focusing on groundbreaking RNA-targeted therapeutics and gene therapies for rare diseases. As a commercial-stage biopharmaceutical..

Krystal Biotech, Inc. (KRYS) Investor Outlook: A Promising Biotech with a 6% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector with its focus on developing genetic medicines for diseases with significant unmet medical needs. With a market capitalization..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech Gem with a 44% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK), a pioneer in the biotechnology sector, is capturing investor attention with its impressive potential for growth. This late-stage biopharmaceutical company is focused on the discovery, development,..

Axsome Therapeutics (AXSM) Stock Analysis: A 63% Revenue Growth Fuels a Promising Biotech Play

For investors seeking dynamic opportunities in the biotechnology sector, Axsome Therapeutics, Inc. (NASDAQ: AXSM) presents an intriguing proposition. As a biopharmaceutical firm focused on central nervous system (CNS) disorders, Axsome..

Option Care Health, Inc. (OPCH) Stock Analysis: Riding a 17% Potential Upside Wave in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) is making waves in the healthcare sector, particularly within the medical care facilities industry, thanks to its innovative home and alternate site infusion services...

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Strong Growth Potential Amidst Analyst Optimism

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands as a compelling prospect in the healthcare sector, specifically within the burgeoning medical devices industry. Known for its innovative approaches to treating obstructive..

Prestige Consumer Healthcare (PBH) Stock Analysis: Is a 17.34% Potential Upside Worth the Investment?

Investors looking for opportunities in the healthcare sector might find Prestige Consumer Healthcare Inc. (NYSE: PBH) an intriguing prospect, especially given the company’s potential upside of 17.34%. Specializing in over-the-counter..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Navigating its Growth Trajectory with 3.39% Potential Upside

Akero Therapeutics, Inc. (NASDAQ: AKRO), a burgeoning entity in the biotechnology sector, has caught the attention of investors with its focus on developing groundbreaking treatments for serious metabolic diseases. Headquartered..

RadNet, Inc. (RDNT) Stock Analysis: Unpacking a 32% Upside Potential Amid Healthcare Expansion

RadNet, Inc. (NASDAQ: RDNT), a pivotal player in the Healthcare sector and specialized in the Diagnostics & Research industry, is capturing investor attention with its remarkable growth potential. With a..

BrightSpring Health Services (BTSG) Rating Update: 16 Buy Ratings Signal Strong Growth Potential

BrightSpring Health Services, Inc. (BTSG) stands out in the healthcare sector, delivering robust growth and attracting significant investor interest. With a market capitalization of $7.16 billion, this U.S.-based company is..

Genmab A/S (GMAB) Stock Analysis: Biotechnology Giant Poised for 22.75% Upside with Strong Buy Ratings

Investors eyeing the healthcare sector often turn their attention to Genmab A/S (NASDAQ: GMAB), a leading biotechnology company headquartered in Copenhagen, Denmark. With a robust market capitalization of $19.03 billion,..

Revvity, Inc. (RVTY) Stock Analysis: A Potential 17.69% Upside in the Healthcare Diagnostics Sector

For investors with an interest in the healthcare sector, Revvity, Inc. (NYSE: RVTY) presents a compelling opportunity. With a market capitalization of $11.79 billion, this U.S.-based company operates in the..

BioNTech SE (BNTX) Stock Analysis: A 31.79% Upside Potential Amidst Promising Clinical Trials

BioNTech SE (NASDAQ: BNTX), a leading player in the biotechnology sector, has been making waves in the healthcare industry with its cutting-edge immunotherapies targeting cancer and infectious diseases. Headquartered in..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 53.95% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector with its innovative approach to treating B-cell mediated diseases. As a commercial-stage biopharmaceutical company, TG Therapeutics is not..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds